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Objectives Although influenza-like illnesses (ILI) and acute
respiratory illnesses (ARI) surveillance are well established in
Europe, the comparability of intensity among countries and seasons
remains an unresolved challenge. The objective is to compare the
intensity of ILI and ARI in some European countries.
Design and setting Weekly ILI and ARI incidence rates and
proportion of primary care consultations were modeled in 28
countries for the 1996/1997–2013/2014 seasons using the moving
epidemic method (MEM). We calculated the epidemic threshold
and three intensity thresholds, which delimit five intensity levels:
baseline, low, medium, high, and very high. The intensity of 2013/
2014 season is described and compared by country.
Results The lowest ILI epidemic thresholds appeared in Sweden
and Estonia (below 10 cases per 100 000) and the highest in
Belgium, Denmark, Hungary, Poland, Serbia, and Slovakia (above
100 per 100 000). The 2009/2010 season was the most intense, with
35% of the countries showing high or very high intensity levels. The
European epidemic period in season 2013/2014 started in January
2014 in Spain, Poland, and Greece. The intensity was between low
and medium and only Greece reached the high intensity level, in
weeks 7 to 9/2014. Some countries remained at the baseline level
throughout the entire surveillance period.
Conclusions Epidemic and intensity thresholds varied by country.
Influenza-like illnesses and ARI levels normalized by MEM in 2013/
2014 showed that the intensity of the season in Europe was between
low and medium in most of the countries. Comparing intensity
among seasons or countries is essential for understanding patterns
in seasonal epidemics. An automated standardized model for
comparison should be implemented at national and international
levels.
Keywords Incidence, influenza-like illnesses, primary care, surveil-
lance.
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Introduction
Influenza and other respiratory virus infections are the most
common causes of primary care consultation and represent
an important economic burden worldwide.1–4 In a typical
season, annual attack rate of influenza is estimated at 5–10%
in adults and 20–30% in children,5 although not all cases seek
medical care and are captured by the surveillance systems.
It is widely accepted that influenza surveillance should
address the following objectives: monitoring the circulating
virus strains, the timing, intensity and severity of the
epidemic waves, providing information about the underlying
risk conditions associated with severity as well as supplying
epidemiological and virological support for pandemic early
warning and preparedness.6
Influenza surveillance is supported by quantitative and
qualitative indicators aimed at assessing the burden of
seasonal epidemics. Such indicators are principally based on
clinical consultations in general practice, hospitalized labo-
ratory-confirmed cases, sentinel and non-sentinel positive
specimens, mortality, and local outbreaks. One of the most
important indicators in influenza surveillance is the esti-
mated incidence or percentage of consultations in a popu-
lation in a given period, which are related to the intensity of
seasonal epidemics. Overall seasonal or weekly influenza




234 ª 2015 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
influenza epidemics and for comparing trends within a
country or intercountry differences. However, evaluating the
impact of prevention and control measures7 needs a reliable
morbidity assessment.
Influenza-like illness (ILI) and acute respiratory infection
(ARI) population-based consultation rates in primary care
settings are the most common quantitative indicators in
Europe and other developed countries, in either sentinel or
universal surveillance systems. The percentage of consulta-
tions due to ILI or ARI is used in countries where a
population denominator is not available.
In the WHO European Region, intensity is reported, via
web-based platforms, as a qualitative indicator based on the
overall level of clinical ILI or ARI consultations in the country
or at subnational level, in comparison with the historical data
available.8 The ILI or ARI consultation rate or weekly
percentage of consultations due to ILI or ARI are subjectively
evaluated by the local epidemiologist as low (no activity or
activity at the baseline level), medium (usual levels of
activity), high (levels of activity higher than usual), and very
high (exceptionally high levels of activity). In the United
States of America, intensity levels are divided into four
categories (minimal, low, moderate, and high) according to
the number of standard deviations above the national
baseline (average percent of ILI visits that occur during
weeks with little or no influenza virus circulation).9
National and international institutions have implemented
surveillance systems for which the comparability of indica-
tors (rates, intensity, trend, geographic spread, etc.) is an
important goal. Several methods to establish epidemic
thresholds and intensity levels have been developed and are
being used in an increasing number of countries.10–13 With
their advantages and limitations, these methods could be
used for regional, national, and international comparison,
provided that they are calculated with the same mathematical
methods and parameters over time. The moving epidemic
method (MEM) model14 is being used in web platforms in
Europe for weekly reports. This pilot experience is based on
data collected through the European Influenza Surveillance
Network (EISN), under coordination by the European
Centre for Disease Prevention and Control (ECDC), Sweden,
since 2011/2012 and through the EuroFlu platform (WHO
Regional Office for Europe), Denmark, since 2012/2013.
Primarily developed to detect the beginning of epidemic
periods through ‘epidemic thresholds,’ MEM calculates
different ‘intensity thresholds’ to weekly monitor the inten-
sity level of the ILI or ARI waves. The experience accumu-
lated in these three seasons has made it possible to review the
methods, explore more output possibilities, and look at the
benefit of having this tool at the national and international
levels.
The objectives of this article were to describe the epidemic
and intensity thresholds of ILI and ARI calculated by MEM
and the intensity of influenza seasons in some European
countries. We also discuss whether these indicators accu-
rately summarize the season epidemics and the usefulness of
this method for comparisons at the national and interna-
tional levels.
Methods
Weekly ILI and ARI incidence rates or proportions of
primary care consultations from the 1996/1997 to the 2013/
2014 influenza season (from week 40 to week 20 of the next
year) were taken from the EuroFlu database (WHO Regional
Office for Europe). Countries included in the study were
selected among the 50 participating Member States in the
WHO European Region, according to the following criteria:
data available for at least six consecutive seasons, excluding
the pandemic season 2009/2010 (a minimum of five seasons
for the calculations and the target season), and no major
changes in the surveillance systems during the reporting
period. Countries fulfilling these criteria were invited to
participate.
Data were checked for inconsistencies, such as abnormal
weekly estimates or missing values during the surveillance
period, and sent to the country representatives for validation
and updating when necessary.
A sequential analysis using the R Language implementa-
tion of MEM (package “mem” [Internet]. Available from:
http://cran.r-project.org/web/packages/mem/index.html)
was carried out for each country to calculate the epidemic
threshold (level of influenza activity that signals the start and
end of the annual epidemic wave) and the three intensity
thresholds (medium, high, and very high) for each season.
The number of seasons included in each analysis ranged from
five to 10 (training period).
Moving epidemic method has three main steps, which
have been previously described.14 In the first step, for each
season separately, the length of the epidemic period is
estimated as the minimum number of consecutive weeks
with the maximum accumulated percentage rates, splitting
the season in three periods: a pre-epidemic, an epidemic, and
a post-epidemic period. In the second step, MEM calculates
the epidemic threshold as the upper limit of the 95% one-
sided confidence interval of 30 highest pre-epidemic weekly
rates, the n highest for each season taking the whole training
period, was n = 30/number of seasons. In the third step,
medium, high, and very high intensity thresholds were
estimated as the upper limits of the 40%, 90%, and 975%
one-sided confidence intervals of the geometric mean of 30
highest epidemic weekly rates, the n highest for each season
taking the whole training period, were n = 30/number of
seasons. For the purposes of this work, if the medium
intensity threshold is lower than the epidemic threshold, the
epidemic threshold is used for both.
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The intensity levels were defined as follows (Figure 1):
1. Baseline: weekly rate ≤ epidemic threshold.
2. Low: epidemic threshold < weekly rate ≤ medium
intensity threshold.
3. Medium: medium intensity threshold < weekly
rate ≤ high intensity threshold.
4. High: high intensity threshold < weekly rate ≤ very high
intensity threshold.
5. Very high: weekly rate > very high intensity threshold.
For the analysis, at least 5 years of consecutive data were
required to calculate the threshold and intensity levels for the
next season; that is, the analysis started with data from
seasons 1996/1997 to 2000/2001 to estimate the thresholds
for season 2001/2002, or from the first season available in the
country to the fifth one, to estimate the thresholds for the
sixth season. From then on, calculations for each subsequent
season included one more season of data (to a maximum of
10) to estimate the thresholds. The last step of analysis used
data from a maximum of 10 seasons if available (2002/2003
to 2012/2013, excluding the 2009 A(H1N1) pandemic) or at
least five seasons (2007/2008 to 2012/2013, excluding the
pandemic) to make estimations for season 2013/2014. As we
excluded the pandemic season from MEM calculations,
estimations for the 2009/2010 and 2010/2011 season thresh-
olds are the same.
For each country, the highest weekly rate per season (the
season peak) was compared to the intensity thresholds and
described for each of the countries over time. Furthermore, a
log scale of the weekly incidence rates and percentage of
consultations was used to graphically compare and discuss
the season 2013/2014 country intensity levels in Europe.
Finally, weekly maps were drawn to show the spread of the
2013/2014 season intensity in Europe.
Complementary figures in Appendix S1 show the histor-
ical data included in this study, the threshold trend over the
years, and the season 2013/2014 surveillance. Appendix S2 is
an animated gif of the evolution of the 2013/2014 intensity
levels by country.
The R Language (v3.2.0) mem library (v1.4) was used for
calculations of the thresholds and graphic output.
Results
Data
A total of 32 countries fulfilled the inclusion criteria and were
asked to participate in the project. One country did not
participate and three countries did not reply; 28 countries
agreed to participate in this project and authorized the use of
their data.
Influenza-like illnesses or ARI weekly data were available
in 30 datasets (Table 1). Luxembourg and Greece provided
percentage of ILI consultations and Switzerland provided
both ILI incidence and percentage of ILI consultations.
Romania had two datasets, one for ILI and another for
ARI. In eight countries, the dataset contained 18 seasons
(from 1996/1997 to 2013/2014). The minimum number of
seasons available for analysis was eight, in Serbia and
Slovakia.
Epidemic and intensity thresholds
Influenza-like illnesses and ARI weekly incidence rates varied
considerably by country and season and resulted in large
Figure 1. MEM graph model with epidemic
and intensity thresholds, intensity levels, and
the weekly ILI/ARI rate.
– weekly rate > very high intensity threshold.
– High intensity threshold < weekly
rate ≤ very high intensity threshold.
– medium intensity threshold < weekly
rate ≤ high intensity threshold.
– epidemic threshold < weekly rate ≤ medium
intensity threshold.
– weekly rate ≤ epidemic threshold. ILI,
influenza-like illnesses; ARI, acute respiratory
illnesses; MEM, moving epidemic method.
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differences in the calculated thresholds (Table 2a). The
lowest ILI epidemic thresholds (in consultations per
100 000 persons) were observed in Sweden (range, 62–
87), Romania (53–139), and Estonia (74–96). Conversely,
countries such as Belgium, Denmark, Hungary, Poland,
Serbia, and Slovakia had epidemic thresholds above 100 in all
the seasons for which data were available.
Differences among medium to high and very high
intensity thresholds are consistently uniform across time in
most countries. Belgium had the highest very high intensity
threshold in 2009/2010 and 2010/2011, followed by Poland in
2006/2007, Slovakia in 2013/2014, and Spain in 2002/2003.
Countries reporting percentage consultations due to ILI,
such as Greece, Luxembourg, and Switzerland, presented
similar thresholds, ranging from 09% to 18% for the
epidemic threshold through the seasons, to more than 10%
for the very high intensity threshold in some seasons in
Luxemburg and Switzerland.
ARI incidence rate thresholds differed as much across
countries as ILI thresholds did (Table 2b). Kyrgyzstan had
the lowest epidemic threshold and France the highest. Very
high intensity ARI thresholds ranged from 248 (Kyrgyzstan
2011/2012) to 4893 (France 2005/2006).
Moving epidemic method ILI thresholds showed a wider
range than ARI thresholds with very high intensity thresholds
exceeding epidemic thresholds 4- to 11-fold and 1- to 35-
fold for ILI and ARI, respectively, depending on the country
and season. The variations in the MEM thresholds over time
are shown by country in Appendix S1.
Trend in intensity levels across seasons by country
In Norway and the United Kingdom (England and Northern
Ireland), two differentiated waves were observed in season
2009/2010. In these cases, the highest weekly rate in the full
season (including both waves) was considered as the ‘peak
rate’.
Table 1. Countries, type of reported data, and seasons included in the study
Country Data type No. of seasons* Seasons
Belgium ILI weekly rates 14 2000/2001–2013/2014
Denmark ILI weekly rates 18 1996/1997–2013/2014
Estonia ILI weekly rates 9 2005/2006–2013/2014
Greece ILI % of consultations 10 2004/2005–2013/2014
Hungary ILI weekly rates 11 2003/2004–2013/2014
Ireland ILI weekly rates 14 2000/2001–2013/2014
Israel ILI weekly rates 11 2003/2004–2013/2014
Lithuania ILI weekly rates 9 2005/2006–2013/2014
Luxembourg ILI % of consultations 11 2003/2004–2013/2014
Norway ILI weekly rates 9 2005/2006–2013/2014
Poland ILI weekly rates 13 2001/2002–2013/2014
Portugal ILI weekly rates 17 1997/1998–2013/2014
Romania ILI weekly rates 10 2004/2005–2013/2014
Serbia ILI weekly rates 8 2006/2007–2013/2014
Slovakia ILI weekly rates 8 2006/2007–2013/2014
Spain ILI weekly rates 18 1996/1997–2013/2014
Sweden ILI weekly rates 10 2000/2001–2002/2003, 2006/2007–2013/2014
Switzerland (con) ILI % of consultations 18 1996/1997–2013/2014
Switzerland (pop) ILI weekly rates 14 2000/2001–2013/2014
The Netherlands ILI weekly rates 18 1996/1997–2013/2014
United Kingdom (ENG) ILI weekly rates 18 1996/1997–2013/2014
United Kingdom (NIR) ILI weekly rates 13 2001/2002–2013/2014
United Kingdom (SCT) ILI weekly rates 11 1996/1997–2013/2014
Albania ARI weekly rates 15 1999/2000–2013/2014
France ARI weekly rates 18 1996/1997–2013/2014
Kazakhstan ARI weekly rates 12 2002/2003–2013/2014
Kyrgyzstan ARI weekly rates 9 2005/2006–2013/2014
Romania ARI weekly rates 9 2005/2006–2013/2014
Russian Federation ARI weekly rates 18 1996/1997–2013/2014
Ukraine ARI weekly rates 18 1996/1997–2013/2014
ILI, influenza-like illness; ARI, acute respiratory infection.
*Number of seasons available for the study.
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Table 2. (a) Epidemic and intensity thresholds by season and country reporting influenza-like illness (ILI) consultation rate, 2001/2002 to 2013/2014.































Very high intensity threshold
(a)
Belgium – – – – 1670 1682 1721 1705 1765 1765 1730 1689 1785
– – – – 3717 3902 4306 4136 4635 4635 4621 4951 4998
– – – – 7025 7007 7709 7329 8611 8611 8318 8215 8554
9308 9076 9973 9438 11322 11322 10787 10275 10847
Denmark 1796 1774 1763 1717 1707 1666 1600 1607 1356 1356 1355 1152 1148
2906 2747 2941 2951 2989 2901 2774 2501 2356 2356 2354 1911 1946
4820 4894 5186 5065 5217 5021 4733 4972 4134 4134 4128 4151 4207
6027 6317 6663 6432 6673 6399 5993 6736 5301 5301 5292 5849 5916
Estonia – – – – – – – – – – 74 82 96
– – – – – – – – – – 146 150 170
– – – – – – – – – – 535 488 512
– – – – – – – – – – 950 821 833
Greece* – – – – – – – – 14 14 16 18 18
– – – – – – – – 35 35 39 44 42
– – – – – – – – 50 50 59 66 64
59 59 71 80 78
Hungary – – – – – – – 1460 1499 1499 1498 1463 1454
– – – – – – – 2834 3276 3276 3730 3654 3890
– – – – – – – 5956 6209 6209 6725 6448 6608
– – – – – – – 8269 8236 8236 8727 8287 8352
Ireland – – – – 260 255 255 247 246 246 246 192 185
– – – – 400 438 479 467 539 539 583 521 571
– – – – 943 960 984 931 1071 1071 1302 1153 1142
– – – – 1377 1358 1353 1264 1451 1451 1856 1638 1552
Israel – – – – – – – 289 288 288 343 334 362
– – – – – – – 1071 1102 1102 1290 1170 1287
– – – – – – – 2413 2366 2366 2756 2608 2811
– – – – – – – 3454 3317 3317 3855 3717 3970
Lithuania – – – – – – – – – – 112 112 142
– – – – – – – – – – 968 751 999
– – – – – – – – – – 2910 3547 4437
– – – – – – – – – – 4733 7043 8579
Luxembourg* – – – – – – – 14 15 15 17 17 18
– – – – – – – 28 33 33 42 41 48
– – – – – – – 64 73 73 90 86 95
– – – – – – – 93 103 103 127 119 129
Norway – – – – – – – – – – 523 540 660
– – – – – – – – – – 1406 1467 1602
– – – – – – – – – – 2392 2384 2669
– – – – – – – – – – 3025 2955 3345
Poland – – – – – 1096 1119 1172 1127 1127 1128 1211 1392
– – – – – 1267 1463 1564 1673 1673 1804 1788 2294
– – – – – 5760 5975 5839 5943 5943 5842 5491 5981
– – – – – 11248 11128 10453 10408 10408 9819 9014 9136
Portugal – 191 197 206 216 226 223 229 312 312 303 316 328
– 280 295 356 400 397 425 481 486 486 600 700 662
– 947 936 1205 1395 1360 1415 1442 1499 1499 1471 1616 1514
– 1622 1560 2065 2424 2343 2408 2344 2466 2466 2188 2339 2182
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Romania – – – – – – – – 53 53 141 139 131
– – – – – – – – 69 69 141 139 131
– – – – – – – – 210 210 371 346 311
– – – – – – – – 344 344 687 627 545
Serbia – – – – – – – – – – – 1036 1005
– – – – – – – – – – – 1491 1638
– – – – – – – – – – – 2918 3026
– – – – – – – – – – – 3926 3968
Slovakia – – – – – – – – – – – 2644 2651
– – – – – – – – – – – 3988 4343
– – – – – – – – – – – 7928 8323
– – – – – – – – – – – 10740 11096
Spain 818 810 807 787 806 780 760 696 547 547 549 584 589
1515 1732 1666 1686 1918 1861 1846 1787 1689 1689 1602 2044 1966
5757 6094 5663 5287 6093 5644 5586 5395 4877 4877 4310 3656 3322
10387 10627 9726 8763 10157 9215 9113 8792 7793 7793 6675 4729 4188
Sweden – – – – – – 62 64 65 65 67 87 86
– – – – – – 162 165 175 175 177 198 200
– – – – – – 410 383 376 376 363 395 386
– – – – – – 619 555 528 528 498 536 515
Switzerland (con)* 12 12 12 12 12 12 11 10 09 09 09 09 09
40 42 44 43 46 41 40 37 36 36 34 34 34
80 76 73 72 74 78 75 71 65 65 56 57 59
107 100 92 91 92 103 100 94 84 84 70 71 75
Switzerland (pop) – – – – 654 649 668 651 671 671 681 665 729
– – – – 2589 2413 2651 2650 2945 2945 2929 2799 2828
– – – – 4230 4381 4529 4384 4864 4864 4722 4783 4923
– – – – 5255 5703 5739 5476 6071 6071 5832 6062 6290
The Netherlands 547 556 561 578 603 589 569 568 508 508 490 492 524
1187 1223 1117 1139 1259 1254 1101 1016 990 990 911 911 922
2795 2692 2765 2676 2923 2793 2477 2385 2249 2249 1754 1759 1806
4081 3814 4127 3904 4240 3977 3546 3477 3232 3232 2344 2353 2430
United Kingdom
(ENG)
421 417 416 406 404 392 375 285 255 255 193 161 153
863 775 669 645 622 588 512 465 425 425 417 356 342
1929 1961 2038 1857 1909 1764 1341 1300 984 984 782 751 729
2752 2955 3334 2962 3134 2867 2052 2049 1426 1426 1033 1044 1019
United Kingdom
(NIR)
– – – – – 416 547 538 526 526 525 524 521
– – – – – 611 722 737 798 798 900 793 857
– – – – – 1226 1666 1633 1827 1827 2190 2130 2097
– – – – – 1668 2410 2322 2633 2633 3243 3296 3114
United Kingdom
(SCT)
– – – – – – – 390 424 424 430 413 432
– – – – – – – 925 1058 1058 1204 836 842
– – – – – – – 1718 2113 2113 2350 2963 3074
– – – – – – – 2257 2869 2869 3159 5183 5448
(b)
Albania – – – 5229 5301 5262 5268 5217 5120 5120 4727 4513 4138
– – – 5694 5680 5534 5472 5540 5442 5442 5291 5271 5192
– – – 6731 6704 6807 6691 6696 6620 6620 6328 6268 6130
– – – 7247 7213 7460 7313 7281 7218 7218 6849 6766 6597
France 22554 22503 22744 22744 22653 22402 22779 22779 22253 22253 21974 21974 21430
31659 32852 33321 33934 35122 34581 33599 32666 31878 31878 31164 30870 30507
40770 41790 41990 42680 44202 43515 41878 42085 40335 40335 39582 39832 38729
45591 46479 46509 47232 48931 48167 46160 47072 44755 44755 43994 44582 43037
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The countries reporting ILI (Table 3a) with seasons at the
top intensity levels were Greece and the United Kingdom
(Northern Ireland), three seasons each; Ireland, two seasons;
and Luxembourg, Norway, Romania, and the United King-
dom (England and Scotland), one each. In contrast, some
countries did not reach the epidemic thresholds at any time
during some seasons, particularly during the last season
2013/2014, when peaks remained at the baseline level in
Denmark, Romania, Serbia, Slovakia, and the United King-
dom (England, Northern Ireland, and Scotland).
Season 2009/2010 was the most intense according to MEM
peak intensity. In the pandemic season, all countries were
above the medium intensity threshold, with 35% of them at
high or very high intensity levels. High intensity peaks
continued through season 2010/2011, with 41% of countries
at the two top levels, whereas season 2011/2012 showed a
significant decreasing intensity, with 52% of countries at the
baseline or low levels and only 5% at high or very high levels.
In countries reporting ARI (Table 3b), the intensity levels
throughout the countries and seasons were quite similar,
with the highest intensity in seasons 2009/2010 and 2010/
2011 in the Russian Federation.
Intensity of the 2013/2014 season
Figure 2A,B shows the ILI and ARI intensity levels calcu-
lated for season 2013/2014 and the observed peak rate (in a
log scale) by country. Poland, Belgium, Spain, and Hungary
had the highest weekly ILI consultation rate per 100 000
(4645, 3072, 2942, and 2638, respectively), and Romania,
Lithuania, and Sweden had the lowest (62, 160, and 167,
respectively). However, peak weekly consultation rates in
Belgium, Hungary, and Sweden, for instance, remained at
the same low intensity level. Slovakia, Denmark, Romania,
and United Kingdom (England), with peak rates as different
as 2126, 946, 62, and 87, respectively, were at the
baseline.
Countries reporting ARI showed larger differences in peak
rates compared with those reporting ILI, although the
intervals between thresholds were narrower. France (with
an ARI peak rate of 22722), the Russian Federation (with a
peak rate of 7760), or Kyrgyzstan (with 951) were
considered to have the same medium intensity level in
2013/2014. During the last three seasons, Romania (which
reported both ARI and ILI data) showed baseline to medium
intensity levels of ILI consultation rates but medium to high
levels of ARI consultation rates.
Weekly intensity in Europe during the 2013/2014 epidemic
period is represented in Figure 3 and in the animated
Appendix S2. The epidemic period started in Europe in
January 2014 in Poland, Greece, and Spain. Data from
Poland show an increase of the weekly rates in the last two
seasons with relative high pre-epidemic rates, as happens in
countries reporting ARI, which could explain the early start





























Kazakhstan – – – – – – 2319 2317 2338 2338 2312 2346 2335
– – – – – – 3769 3784 3847 3847 3793 3778 3573
– – – – – – 7304 7219 7273 7273 6937 7137 6857
– – – – – – 9786 9604 9638 9638 9058 9455 9147
Kyrgyzstan – – – – – – – – – – 774 752 739
– – – – – – – – – – 1067 1150 1140
– – – – – – – – – – 1916 2050 2101
– – – – – – – – – – 2481 2646 2753
Romania – – – – – – – – – – 6974 7943 7969
– – – – – – – – – – 7723 8076 8445
– – – – – – – – – – 9322 9492 9778
– – – – – – – – – – 10130 10195 10432
Russian
Federation
7161 7169 7167 7158 7207 7180 7162 7135 6957 6957 7004 6755 6912
10162 10171 10710 10450 10436 10099 9721 9481 9113 9113 9126 8888 9027
14290 14279 14673 14285 14528 14256 13425 13289 11621 11621 11781 11722 11960
16614 16589 16863 16402 16816 16602 15483 15427 12939 12939 13189 13248 13544
Ukraine 6756 6828 6828 7034 7027 6936 6913 6859 6430 6430 6232 5910 5880
9466 9431 10132 9611 9998 9396 9341 9188 8478 8478 8089 7636 7556
14692 14699 15677 15166 15729 15484 15313 15289 13826 13826 12183 11108 11090
17843 17884 19013 18555 19216 19309 19052 19147 17162 17162 14600 13109 13140
*Percentage of consultation due to ILI.
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between low and medium, and only Greece reached high
intensity level in weeks 7 to 9/2014.
Discussion
Estimated rates based on ILI and ARI consultations showed
great variability across countries, most likely due to different
health systems, healthcare-seeking behavior, and surveillance
schemes, including case definitions15 and virological surveil-
lance.16 The WHO Regional Office for Europe and the ECDC
receive weekly information on ILI and/or ARI from surveil-
lance systems using either population or consultation denom-
inators as well as qualitative indicators such as intensity, trend,
and geographical spread, by country. Nevertheless, comparing
countries is difficult despite efforts to standardize and remains
a challenge for global influenza surveillance.
The search for a gold standard epidemic threshold and
intensity indicators has been long-standing, particularly as
sentinel surveillance systems were put in place in Europe.
However, there is no final consensus on the method, in spite
of the demands of international organizations and country
authorities. Most of the methods implemented to model
influenza seasons use ad hoc discretionary parameters to
establish the epidemic period,12,17–20 which is one of the
major constraints to comparability.
In this study, we have used defined criteria to calculate
epidemic and intensity thresholds, regardless of the type and
quality of the data and their fit to the model. The data
suggest that intracountry ARI epidemic rates had fewer
variations than ILI rates (Figures S1A), suggesting greater
stability of ARI incidence, according to the multiple origins
of such infections. Consequently, variance is lower, confi-
dence limits (particularly at 90 and 975 CI) are narrower,
and ARI intensity thresholds are more stable than ILI
(Figures S1B). In contrast, ARI pre-epidemic rates usually
vary more, raising epidemic thresholds.
Table 3. (a) Highest influenza-like illness (ILI) weekly consultation rate intensity by season and country (colors indicate the ILI intensity level
corresponding to the highest rate in the season), 2001/2002 to 2013/2014. (b) Highest acute respiratory infections (ARI) weekly consultation rate






























387·6 785·3 380·3 875·9 775·8 491·3 530·6 1025·9 307·2
Denmark 224·2 449·2 450·2 315·9 265·6 280·3 129·7 279·9 421·5 281·9 75·0 241·1 94·6
Estonia 15·5 30·0 18·4
Greece* 8·4 7·8 7·2 3·4 7·3
Hungary 428·1 458·2 587·9 395·6 405·4 263·8
Ireland 82·5 67·6 49·1 120·6 201·3 202·1 41·3 59·7 54·1
Israel 98·2 228·6 256·5 75·4 188·5 133·3
Lithuania 56·3 378·4 16·0
Luxembourg* 7·7 8·6 10·9 4·9 10·2 3·1
Norway 157·2 356·6 66·2
Poland 265·8 166·1 456·4 353·0 232·0 256·2 560·2 464·5
Portugal 42·5 104·7 173·6 30·2 100·2 61·9 165·8 125·8 95·1 141·3 71·0 80·7
Romania 7·5 71·0 7·0 9·3 6·2
Serbia 235·2 99·0
Slovakia 616·7 212·6
Spain 399·3 139·4 222·2 541·4 175·4 259·7 202·8 217·5 371·9 239·6 250·9 229·2 294·2
Sweden 17·6 25·3 34·8 23·1 37·9 26·9 16·7
Switzerland (con)* 4·3 4·3 6·7 6·1 2·1 4·0 3·4 5·6 5·3 3·6 2·9 5·7 1·8
Switzerland (pop) 176·2 343·9 316·0 515·1 461·8 306·2 214·1 491·7 147·4
The Netherlands 124·2 66·3 172·3 240·0 145·3 81·7 71·5 147·9 189·4 105·9 78·0 153·5 73·0
United Kingdom (ENG 46·2 30·6 62·2 40·7 43·7 44·8 32·0 53·1 155·3 124·4 20·2 32·7 8·7
United Kingdom (NIR) 204·2 81·0 196·5 280·6 263·5 36·3 87·0 39·2
United Kingdom (SCT) 325·0 208·5 246·7 18·2 52·1 21·5
Albania 586·4 469·0 553·2 550·9 489·1 517·8 503·6 676·9 516·7 545·3
France 4006·1 3298·4 4187·4 4488·5 3205·9 3360·6 2797·3 3392·9 3139·1 3088·8 2667·4 3387·8 2272·2
Kazakhstan 382·4 399·0 592·6 417·9 290·7 253·9 185·2
Kyrgyzstan 180·4 82·5 95·1
Romania 945·5 979·2 850·3
Russian Federation 907·5 1355·3 1007·9 901·7 850·2 1026·0 849·1 965·8 1399·3 1445·8 778·0 1074·8 776·0
Ukraine 756·1 1454·2 760·6 931·0 661·4 1156·5 832·8 693·7 1501·1 874·2 684·5 690·4 687·6
No estimates
*Percentage of consultation due to ILI.
Baseline level Low intensity level Medium intensity level High intensity level Very high intensity level
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Epidemic and intensity thresholds vary according to the
historical rates in each country with important differences, as
observed, for instance, in Belgium and Sweden. Although this
is an expected finding, these thresholds describe the shape of
the epidemic waves and point out the necessity of a standard
way to make comparisons. Epidemic thresholds are also
influenced by the quality of the surveillance system. Coun-
tries with large variations in pre-epidemic ILI rates had high
epidemic thresholds which, in the case of Romania, were
higher than the medium intensity threshold. Additionally,
the extreme variations in ILI peaks increased the upper
confidence limits of the intensity thresholds, as observed in
Lithuania, the United Kingdom (Scotland), and, again, in
Romania and Slovakia.
Although the season peak rate is not the only indicator of
seasonal intensity, it is useful for assessing and comparing
either intra- or intercountry variations. Other intensity
measures (such as the season-cumulative rate or the area
under the epidemic period curve) could be useful for
comparing seasons and countries, but they are unhelpful




Figure 2. (A) Intensity levels and highest weekly ILI rate by country in the 2013/2014 season. (B) Intensity levels and highest weekly ARI rate by country in
the 2013/2014 season. ILI, influenza-like illnesses; ARI, acute respiratory illnesses.
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Figure 3. Weekly ILI/ARI intensity levels in Europe 2013/2014 during the epidemic period (weeks 01/2014 to 15/2014). ILI, influenza-like illnesses; ARI,
acute respiratory illnesses.
Influenza intensity surveillance
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Moving epidemic method translates quantitative rates (or
percentages of consultations) into a standardized qualitative
intensity values which permit assessing intercountry differ-
ences. ILI peak rates – as different as 3072 in Belgium, 160
in Lithuania, and 167 in Sweden in 2013/2014 – were all
classified as low intensity. Similarly, Luxemburg, with a peak
of 31 ILI cases per 100 consultations, and Hungary, with a
peak of 2638 ILI consultations per 100000 population,
would both be classified as low intensity in 2013/2014. In
contrast, MEM considered the ILI rate of 3566 in Norway in
2012/2013 to be very high and 3803 in Belgium in 2007/2008
as low.
Influenza-like illnesses intensity thresholds tended to
decline as a consequence of the general trend of influenza
in the last decade in Europe. However, an intense season
could increase variability, raise intensity thresholds, and lead
to similar rates qualifying as medium in one season and high
in the following one, as occurred in Albania with 5532 and
5509 in 2006/2007 and 2007/2008, respectively, reflecting the
general trend and locating the current season intensity in the
epidemic context of the past years. From the geographical
point of view, rates in some large countries could vary
considerably from one region to another.21 In these coun-
tries, such as the Russian Federation, for instance, the
thresholds should be calculated at the regional level to give
more accurate information.
The number of seasons included in the calculation,
however, remains a point of discussion. The minimum
number for obtaining stable thresholds was established at
five, and the maximum was limited to 10, to remain in the
latest trend, quite changing in some European countries.22,23
The pandemic season 2009/2010 was omitted because of its
special surveillance characteristics with aberrant rate esti-
mates in some countries. MEM thresholds must be updated
on a yearly basis which, more than an annoyance, is an
opportunity to include the latest trend.
The cut points are just a reference for comparison and
do not affect the meaning of the results. The confidence
intervals (40%, 90% and 975%) used by MEM to establish
the intensity limits have been selected after a descriptive
analysis of all seasons and countries and a final agreement
on the better distribution of the intensity levels in
Europe.24
Some of the principal limitations of this method are
associated with changes of the surveillance system or in
access to primary are, but these problems are common to all
modeling approaches. MEM detects erroneous or outlier
data in the series (as in the 2009/2010 pandemic season),
allowing to decide whether or not to include them in the
calculation.
Other quantitative indicators could also assess the inten-
sity. The cumulative ILI or ARI incidence rate in a season
would be one possibility. However, this rate can only be
estimated at the end of the season, which limits its use in
monitoring. Moreover, as the duration of the epidemic
periods is quite similar, particularly in the case of ILI, weekly
intensity rates (including the peak rate) are a good proxy for
the overall intensity of one season.
New approaches for intensity assessment should include
virological information to confirm and quantify virus
circulation and to predict epidemic size.25 The percentage
of influenza virus detection could be included for assessing
ILI epidemic intensity, as some authors26 have already done,
as well as standard registers for studying the severity of cases.
Nevertheless, assuming that these figures could reliably
reflect the epidemic activity in a country, these indicators
are conditioned by the health system, health resources,
laboratory capacity, and health practice, which makes
comparison almost impossible. In the 2013–2014 season,
principal influenza strains circulating in Europe were A/
California/7/2009 (H1N1)-like (58% of all isolations), A/
Texas/50/2012 (H3N2)-like (38%), and type B/Yamagata
lineage viruses (4%), and no major differences were observed
between countries that could explain the weekly rate
variations.
Although MEM was primarily developed for modeling ILI
data, it has been used successfully with ARI data.14 MEM
thresholds suggest that ARI waves are quite different from ILI
ones, with higher epidemic thresholds and shorter range
among intensity thresholds. ILI, mainly caused by the
influenza virus, has much higher epidemic waves than ARI
and lower and stable pre-epidemic weekly rates. A large
distance from epidemic threshold to very high intensity
threshold in ILI is consistent with this (high range between
thresholds). On the contrary, ARI is caused by a wide
number of different microorganisms which leads to a great
variation in pre-epidemic rates and to low epidemic waves
with similar shapes each year (low range between thresholds).
In these cases, complementary virological information could
be necessary for determining the start of the epidemic wave
to avoid false alarms. Laboratory-confirmed respiratory
infection outbreaks or any important increase in positive
swabs should be monitored to evaluate the overall influenza
epidemic situation.
Intensity, understood as the level of the population
consultation rates or the percentage of ILI or ARI primary
care consultations, is not synonymous with activity or
severity, but is one of the most valid and reliable indicators
for the impact of influenza on the population. Comparing
intensity across seasons or countries is essential for under-
standing the epidemic patterns of seasonal epidemics and
future pandemics, and for evaluating control measures, such
as the effectiveness of vaccination campaigns. Consequently,
an automated standardized model for comparison should
replace the subjective intensity reports in surveillance systems
at national and international levels.
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